Intensity Therapeutics, Inc.
USD4.40
-0.30 (-6.38%)
CEO
Lewis H. Bender
IPO Date
2023-06-30
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$4.62
Prev. Close
$4.70
Day Low
$4.37
Day High
$4.75
52W Low
$3.51
52W High
$43.50
Market Cap
$0.01B
Volume
0.02M
| 1,093 |
| $3.48 |
| 30 Mar 2026 | BENDER LEWIS H | director, officer: President and CEO | A-Award | Acquired | 37,749 | $6.11 |
| 5 Jan 2026 | Wesolowski John M | Principal Accounting Officer | A-Award | Acquired | 8,918 | $0.26 |
| 5 Jan 2026 | Talamo Joseph | Chief Financial Officer | A-Award | Acquired | 14,482 | $0.26 |
| 2 Jul 2025 | Wesolowski John M | Principal Accounting Officer | A-Award | Acquired | 69,745 | $0.26 |
| 2 Jul 2025 | Talamo Joseph | Chief Financial Officer | A-Award | Acquired | 14,179 | $0.26 |
| 6 May 2025 | DUBIN THOMAS I H | director | A-Award | Acquired | 50,000 | $0.57 |
| 6 May 2025 | Talamo Joseph | Chief Financial Officer | A-Award | Acquired | 300,000 | $0.57 |
| 23 Oct 2024 | Talamo Joseph | Chief Financial Officer | A-Award | Acquired | 427,379 | $3.44 |